Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
124M
-
Number of holders
-
78
-
Total shares
-
29.7M
-
Shares change
-
+591K
-
Total reported value, excl. options
-
$528M
-
Value change
-
+$9.56M
-
Number of buys
-
43
-
Number of sells
-
-27
-
Price
-
$17.78
Significant Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q3 2018
77 filings reported holding APLS - Apellis Pharmaceuticals, Inc. - Common Stock as of Q3 2018.
Apellis Pharmaceuticals, Inc. - Common Stock (APLS) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.7M shares
of 124M outstanding shares and own 23.88% of the company stock.
Largest 10 shareholders include Hillhouse Capital Management, Ltd. (4.33M shares), Cormorant Asset Management, LP (4.17M shares), BlackRock Inc. (2.85M shares), Sectoral Asset Management Inc (2.04M shares), Vanguard Group Inc (1.41M shares), STATE STREET CORP (1.36M shares), Vivo Capital, LLC (1.35M shares), VICTORY CAPITAL MANAGEMENT INC (1.35M shares), MILLENNIUM MANAGEMENT LLC (1.11M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (911K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.